A. McCormick

D. Webster, M. Macartney, T. Conibear, 2013, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Mouse cytomegalovirus M36 and M45 death suppressors cooperate to prevent inflammation resulting from antiviral programmed cell death pathways

W. Kaiser, E. Mocarski, Yanjun Feng, 2017, Proceedings of the National Academy of Sciences.

Gene products of the embedded m41/m41.1 locus of murine cytomegalovirus differentially influence replication and pathogenesis.

E. Mocarski, A. McCormick, Lynsey N Crosby, 2013, Virology.

The Nucleotidylylation of Herpes Simplex Virus 1 Regulatory Protein α22 by Human Casein Kinase II*

B. Roizman, J. Blaho, A. McCormick, 1997, The Journal of Biological Chemistry.

A cytomegalovirus-encoded inhibitor of apoptosis that suppresses caspase-8 activation

T. Chittenden, E. Mocarski, V. Goldmacher, 2001, Proceedings of the National Academy of Sciences of the United States of America.

Evaluation of sequencing of HCV core/E1, NS5A and NS5B as a genotype predictive tool in comparison with commercial assays targeting 5'UTR.

D. Webster, Colette Smith, M. Macartney, 2015, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Ultra-deep sequencing provides insights into the virology of hepatitis C super-infections in a case of three sequential infections with different genotypes.

R. Rigatti, D. Webster, L. Waters, 2015, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Telaprevir or boceprevir based therapy for chronic hepatitis C infection: development of resistance-associated variants in treatment failure.

P. Trembling, W. Rosenberg, S. Tanwar, 2014, Antiviral research.

Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial.

A. Breckenridge, P. Kaleebu, D. Pillay, 2010, Lancet.

High Rate of HIV Resuppression After Viral Failure on First-line Antiretroviral Therapy in the Absence of Switch to Second-line Therapy

A. Breckenridge, P. Kaleebu, D. Pillay, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Analysis of transmitted HIV-1 drug resistance using 454 ultra-deep-sequencing and the DeepChek®-HIV system

D. Webster, M. Johnson, C. Sayada, 2014, Journal of the International AIDS Society.

Prevalence of Baseline Polymorphisms for Potential Resistance to NS5A Inhibitors in Drug-Naive Individuals Infected with Hepatitis C Genotypes 1–4

D. Webster, M. Macartney, T. Haque, 2014, Antiviral therapy.

International Congress of Drug Therapy in HIV Infection 2‐6 November 2014, Glasgow, UK

Samit R. Joshi, Charlene A Flash, Thomas Lengauer, 2014 .

Differential function and expression of the viral inhibitor of caspase 8-induced apoptosis (vICA) and the viral mitochondria-localized inhibitor of apoptosis (vMIA) cell death suppressors conserved in primate and rodent cytomegaloviruses.

P. Barry, E. Mocarski, V. Goldmacher, 2003, Virology.

Multiplicity-dependent activation of a serine protease-dependent cytomegalovirus-associated programmed cell death pathway.

E. Mocarski, L. Roback, A. McCormick, 2013, Virology.

Frequent Occult Infection with Cytomegalovirus in Cardiac Transplant Recipients despite Antiviral Prophylaxis

H. Valantine, J. Cooke, L. Potena, 2007, Journal of Clinical Microbiology.

A HML6 endogenous retrovirus on chromosome 3 is upregulated in amyotrophic lateral sclerosis motor cortex

Ashley R. Jones, A. Al-Chalabi, C. Troakes, 2021, Scientific Reports.

Lack of minority K65R-resistant viral populations detected after repeated treatment interruptions of tenofovir/zidovudine and lamivudine in a resource-limited setting.

D. Pillay, C. Gilks, P. Katundu, 2010, Journal of acquired immune deficiency syndromes.

Gag-Protease Sequence Evolution Following Protease Inhibitor Monotherapy Treatment Failure in HIV-1 Viruses Circulating in East Africa

P. Kaleebu, D. Pillay, Ravindra K. Gupta, 2015, AIDS research and human retroviruses.

Evidence for Reduced Drug Susceptibility without Emergence of Major Protease Mutations following Protease Inhibitor Monotherapy Failure in the SARA Trial

Deenan Pillay, Pontiano Kaleebu, Anne Kapaata, 2015, PloS one.

Virological findings from the SARA trial: boosted PI monotherapy as maintenance second-line ART in Africa

P. Kaleebu, D. Pillay, D. Gibb, 2010, Journal of the International AIDS Society.

Viral rebound and emergence of drug resistance in the absence of viral load testing: a randomized comparison between zidovudine-lamivudine plus Nevirapine and zidovudine-lamivudine plus Abacavir.

P. Kaleebu, D. Pillay, C. Gilks, 2010, The Journal of infectious diseases.

Quantitative analysis of human endogenous retrovirus-K transcripts in postmortem premotor cortex fails to confirm elevated expression of HERV-K RNA in amyotrophic lateral sclerosis

A. Al-Chalabi, J. Huggett, J. Garson, 2019, Acta neuropathologica communications.

IL28B genotype predicts response to chronic hepatitis C triple therapy with telaprevir or boceprevir in treatment naïve and treatment-experienced patients other than prior partial- and null-responders

W. Rosenberg, M. Jacobs, G. Dusheiko, 2015, SpringerPlus.

The utility of genotypic tropism testing in clinical practice

H. Wyatt, M. Johnson, M. Macartney, 2015, International journal of STD & AIDS.

Phenotypic and genotypic analyses to guide selection of reverse transcriptase inhibitors in second-line HIV therapy following extended virological failure in Uganda

D. Pillay, J. Kigozi, E. Katabira, 2014, The Journal of antimicrobial chemotherapy.

The impact of virologic resistance and adherence on treatment failure in a cohort of hepatitis C virus (HCV) infected patients treated with telaprevir (TVR) and boceprevir (BOC)

P. Trembling, W. Rosenberg, S. Tanwar, 2012 .

Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial

A. Breckenridge, P. Kaleebu, D. Pillay, 2010, The Lancet.